Green tea, derived from the leaves of Camellia sinensis that undergo minimal oxidation, is celebrated worldwide for its delicate flavor and long-standing reputation as a health‑promoting beverage. Unlike black or oolong teas, green tea is classified as unfermented (0 % oxidation), which preserves a high concentration of polyphenolic compounds, particularly catechins. Historical Chinese texts such as Lu Yu’s The Classic of Tea (Cha Jing, circa 760 CE) already noted tea’s ability to “quiet the mind and aid digestion,” while traditional Japanese tea ceremonies emphasized its role in cultivating mindfulness. Modern scientific inquiry has shifted from anecdotal praise to rigorous investigation, isolating the bioactive molecules responsible for observed effects and quantifying their potential benefits. This article summarizes the current evidence‑based understanding of green tea’s health properties, focusing on areas where research provides measurable support while acknowledging the limits of extrapolation from laboratory or epidemiological data.

Antioxidant Properties and Cellular Protection

One of the most consistently documented effects of green tea is its capacity to scavenge reactive oxygen species (ROS) and bolster endogenous antioxidant defenses. The principal actors are catechins, a subclass of flavonoids that constitute up to 30 % of the dry weight of green tea leaves. The most abundant catechin is epigallocatechin‑3‑gallate (EGCG), typically representing 50‑80 % of the total catechin pool. Analytical studies report that a standard 240 mL cup of brewed green tea (≈2 g leaf) delivers between 200‑300 mg of total catechins, of which EGCG accounts for roughly 60‑100 mg, depending on varietal, growing conditions, brewing temperature (usually 70‑80 °C), and steeping time (2‑3 minutes).

In vitro assays demonstrate that EGCG can neutralize superoxide, hydroxyl, and peroxyl radicals with rate constants comparable to those of vitamin C and vitamin E. Human supplementation trials have shown measurable increases in plasma antioxidant capacity after consuming 400‑800 mg of green tea catechin extract daily for 4‑12 weeks. For example, a randomized, double‑blind study of 60 healthy adults found a 15‑20 % rise in serum ferric‑reducing antioxidant power (FRAP) after 8 weeks of 500 mg EGCG supplementation (Journal of Nutritional Biochemistry, 2018). While these changes reflect enhanced antioxidant status, translating them directly into clinical outcomes such as reduced disease incidence requires cautious interpretation, as oxidative stress is only one of many pathogenic pathways.

Cardiovascular Health

Epidemiological observations linking regular green tea consumption with lower rates of cardiovascular disease (CVD) have motivated mechanistic research. Meta‑analyses of prospective cohort studies suggest that individuals who drink three or more cups per day experience a 10‑20 % reduction in risk of coronary artery disease and stroke compared with non‑drinkers (European Journal of Preventive Cardiology, 2021). The magnitude of benefit appears dose‑responsive, with each additional cup associated with roughly a 2‑3 % decrement in CVD risk.

Several physiological mechanisms have been identified:

  • Blood pressure modulation: Short‑term studies report modest reductions in systolic blood pressure (SBP) of 2‑4 mmHg and diastolic blood pressure (DBP) of 1‑2 mmHg after 4‑12 weeks of green tea catechin intake (300‑600 mg/day). A 2020 crossover trial of 45 pre‑hypertensive participants observed a mean SBP decrease of 3.5 mmHg following daily consumption of three cups of green tea (American Journal of Hypertension).
  • Lipid profile improvement: Randomized controlled trials consistently show decreases in low‑density lipoprotein cholesterol (LDL‑C) ranging from 5‑10 % and increases in high‑density lipoprotein cholesterol (HDL‑C) of 2‑4 % after 8‑12 weeks of green tea extract supplementation (equivalent to 500‑1000 mg catechins). A 2019 meta‑analysis of 14 RCTs concluded that green tea consumption lowered LDL‑C by an average of 0.12 mmol/L (Nutrition Reviews).
  • Endothelial function: Flow‑mediated dilation (FMD), a surrogate of endothelial health, improves by 1‑3 % after acute ingestion of 200‑400 mg EGCG, likely due to increased nitric oxide bioavailability and reduced oxidative stress (Hypertension Research, 2017).

Collectively, these data support a role for green tea as a